Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22) 22
male (21) 21
index medicus (19) 19
prostate cancer (16) 16
aged (14) 14
middle aged (13) 13
urology & nephrology (12) 12
cancer (11) 11
radical prostatectomy (10) 10
prostate (9) 9
research (9) 9
prostatic neoplasms - therapy (8) 8
radiotherapy (8) 8
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (7) 7
journal article (7) 7
men (7) 7
prostatic neoplasms - surgery (7) 7
surgery (7) 7
analysis (6) 6
biopsy (6) 6
carcinoma (6) 6
prostate-specific antigen - blood (6) 6
prostatic neoplasms - pathology (6) 6
treatment outcome (6) 6
care and treatment (5) 5
clinical trials (5) 5
dk/atira/pure/core/keywords/brtc (5) 5
intervention (5) 5
mortality (5) 5
design (4) 4
dk/atira/pure/researchoutput/pubmedpublicationtype/d013485 (4) 4
medicine, general & internal (4) 4
oncology (4) 4
oncology, experimental (4) 4
patients (4) 4
prostate - pathology (4) 4
prostate-specific antigen (4) 4
prostatectomy (4) 4
prostatic neoplasms - diagnosis (4) 4
prostatic neoplasms - mortality (4) 4
public, environmental & occupational health (4) 4
quality of life (4) 4
quality-of-life (4) 4
radiation therapy (4) 4
randomization (4) 4
research support, non-u.s. gov't (4) 4
retrospective studies (4) 4
united kingdom (4) 4
abridged index medicus (3) 3
adenocarcinoma (3) 3
aged, 80 and over (3) 3
cohort studies (3) 3
differentiation (3) 3
disease progression (3) 3
expression (3) 3
feasibility studies (3) 3
follow-up (3) 3
further section (3) 3
health aspects (3) 3
hyperplasia (3) 3
patient outcomes (3) 3
pilot projects (3) 3
prostatic neoplasms - blood (3) 3
prostatic neoplasms - radiotherapy (3) 3
randomized controlled trial (3) 3
recruitment (3) 3
risk (3) 3
surveys and questionnaires (3) 3
tumors (3) 3
usage (3) 3
validation (3) 3
watchful waiting (3) 3
active surveillance (2) 2
adjustment (2) 2
adult (2) 2
age factors (2) 2
androgen (2) 2
article (2) 2
cancer surgery (2) 2
cancer therapies (2) 2
cell division - drug effects (2) 2
clinical outcomes (2) 2
clinical protocols (2) 2
clinical-trials (2) 2
coculture techniques (2) 2
comparative studies (2) 2
comparative study (2) 2
comprehensive cohort (2) 2
diagnosis (2) 2
dk/atira/pure/researchoutput/pubmedpublicationtype/d003160 (2) 2
dk/atira/pure/researchoutput/pubmedpublicationtype/d016449 (2) 2
drug therapy (2) 2
early detection of cancer (2) 2
endocrinology & metabolism (2) 2
epithelial cells - cytology (2) 2
epithelial cells - ultrastructure (2) 2
epithelial-cells (2) 2
erectile dysfunction (2) 2
female (2) 2
fibroblasts - ultrastructure (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
by Hamdy, Freddie C and Donovan, Jenny L and Lane, J. Athene and Mason, Malcolm and Metcalfe, Chris and Holding, Peter and Davis, Michael and Peters, Tim J and Turner, Emma L and Martin, Richard M and Oxley, Jon and Robinson, Mary and Staffurth, John and Walsh, Eleanor and Bollina, Prasad and Catto, James and Doble, Andrew and Doherty, Alan and Gillatt, David and Kockelbergh, Roger and Kynaston, Howard and Paul, Alan and Powell, Philip and Prescott, Stephen and Rosario, Derek J and Rowe, Edward and Neal, David E and ProtecT Study Grp and ProtecT Study Group
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 15, pp. 1415 - 1424
In the ProtecT trial, over 1600 men with PSA-detected localized prostate cancer were assigned to active monitoring, prostatectomy, or radiotherapy. Although... 
CLUSTER RANDOMIZED-TRIAL | MORTALITY | RATES | MEDICINE, GENERAL & INTERNAL | DESIGN | SCREENING TRIAL | CONFORMAL RADIOTHERAPY | RADICAL PROSTATECTOMY | DEATH | ACTIVE-SURVEILLANCE | RT01 TRIAL | Prostatic Neoplasms - radiotherapy | Age Factors | Follow-Up Studies | Outcome Assessment (Health Care) | Prostatic Neoplasms - surgery | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Neoplasm Metastasis | Comparative Effectiveness Research | Prostatectomy | Watchful Waiting | Aged | Care and treatment | Usage | Patient outcomes | Surgery | Research | Radiotherapy | Prostate cancer | Patients | Health aspects | Prostate-specific antigen | Mortality | Comparative studies | Radiation therapy | Prostate | Clinical outcomes | Cancer surgery | Metastases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Characterizing the phase purity of nanocrystalline Fe3O4 thin films using Verwey transition
by Bohra, Murtaza and Prasad, K. Eswar and Bollina, Ravi and Sahoo, S.C and Kumar, Naresh
Journal of Magnetism and Magnetic Materials, ISSN 0304-8853, 11/2016, Volume 418, pp. 137 - 142
We have employed Verwey transition as a probe to check phase purity of nanocrystalline Fe O films grown at different substrate temperatures ( ) by means of... 
Verwey transition | Easy magnetization axis of Fe3O4 | Wet H2 reduction | Easy magnetization axis of Fe | reduction | Wet H | MAGNETORESISTANCE | ROOM-TEMPERATURE | PHYSICS, CONDENSED MATTER | TRANSPORT-PROPERTIES | DEPOSITION | MATERIALS SCIENCE, MULTIDISCIPLINARY | MAGNETIC-PROPERTIES | Wet H-2 reduction
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
by Donovan, Jenny L and Hamdy, Freddie C and Lane, J. Athene and Mason, Malcolm and Metcalfe, Chris and Walsh, Eleanor and Blazeby, Jane M and Peters, Tim J and Holding, Peter and Bonnington, Susan and Lennon, Teresa and Bradshaw, Lynne and Cooper, Deborah and Herbert, Phillipa and Howson, Joanne and Jones, Amanda and Lyons, Norma and Salter, Elizabeth and Thompson, Pauline and Tidball, Sarah and Blaikie, Jan and Gray, Catherine and Bollina, Prasad and Catto, James and Doble, Andrew and Doherty, Alan and Gillatt, David and Kockelbergh, Roger and Kynaston, Howard and Paul, Alan and Powell, Philip and Prescott, Stephen and Rosario, Derek J and Rowe, Edward and Davis, Michael and Turner, Emma L and Martin, Richard M and Neal, David E and ProtecT Study Grp and ProtecT Study Group
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 15, pp. 1425 - 1437
The choice of treatment for PSA-detected, localized prostate cancer is influenced by effects of the interventions on quality of life. In the ProtecT trial,... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | ACTIVE SURVEILLANCE | MEN | VALIDATION | RADICAL PROSTATECTOMY | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | INTERVENTION | URINARY-INCONTINENCE | Erectile Dysfunction | Prostatic Neoplasms - radiotherapy | Outcome Assessment (Health Care) | Prostatic Neoplasms - surgery | Humans | Middle Aged | Digestive System Diseases | Male | Treatment Outcome | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Intention to Treat Analysis | Quality of Life | Urologic Diseases | Prostatectomy | Surveys and Questionnaires | Watchful Waiting | Aged | Health Status | Care and treatment | Usage | Patient outcomes | Surgery | Analysis | Research | Radiotherapy | Prostate cancer | Patients | Health aspects | Quality of life | Clinical trials | Data processing | Radiation therapy | Mental depression | Clinical outcomes | Cancer surgery | Motivation | Intestine | Comparative studies | Anxiety | Prostate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Four‐year outcomes from a multiparametric magnetic resonance imaging (MRI)‐based active surveillance programme: PSA dynamics and serial MRI scans allow omission of protocol biopsies
by Gallagher, Kevin Michael and Christopher, Edward and Cameron, Andrew James and Little, Scott and Innes, Alasdair and Davis, Gill and Keanie, Julian and Bollina, Prasad and McNeill, Alan
BJU International, ISSN 1464-4096, 03/2019, Volume 123, Issue 3, pp. 429 - 438
Objectives To report outcomes from a multiparametric (mp) magnetic resonance imaging (MRI)‐based active surveillance programme that did not include performing... 
prostate biopsy | prostate cancer | MRI scan | active surveillance | PRIAS | KINETICS | PROSTATE-CANCER | MEN | UROLOGY & NEPHROLOGY | Magnetic resonance imaging | Prostate cancer | Nuclear magnetic resonance--NMR | Surveillance | Biopsy | Prostate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Development of a complex intervention improved randomization and informed consent in a randomized controlled trial
by Donovan, Jenny L and Athene Lane, J and Peters, Tim J and Brindle, Lucy and Salter, Elizabeth and Gillatt, David and Powell, Philip and Bollina, Prasad and Neal, David E and Hamdy, Freddie C and ProtecT Study Grp and ProtecT Study Group
Journal of Clinical Epidemiology, ISSN 0895-4356, 2008, Volume 62, Issue 1, pp. 29 - 36
Abstract Objective Multicenter randomized trials are required for pragmatic evaluations of health care interventions, but recruitment is difficult. Systematic... 
Internal Medicine | Qualitative research methods | Randomization | ProtecT study | Randomized controlled trial | Prostate cancer | Recruitment | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | QUALITY | CLINICAL-TRIALS | CANCER | PARTICIPATION | PROTECT | Outcome Assessment (Health Care) - methods | Humans | Middle Aged | Medical Audit | Male | United Kingdom | Random Allocation | Disclosure | Patient Selection | Prostatic Neoplasms - therapy | Informed Consent | Aged | Qualitative Research | Informed consent (Medical law)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text MP73-13 DO FRAILER MEN BENEFIT FROM TURP?: A PROSPECTIVE AUDIT OF URO-FRAILTY MDT ASSESSMENT
by Good, Daniel and Jones, Helen and Drybrugh, Becky and Tsavalas, Panos and Foo, Irwin and MacDonald, Elizabeth and Bollina, Prasad
The Journal of Urology, ISSN 0022-5347, 04/2018, Volume 199, Issue 4, pp. e996 - e996
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study
by Donovan, Jenny L and Opmeer, Brent and Young, Grace J and Mills, Nicola and Martin, Richard M and Lane, J. Athene and Metcalfe, Chris and Peters, Tim J and Davis, Michael and Turner, Emma L and Walsh, Eleanor and Neal, David E and Hamdy, Freddie C and ProtecT Study Grp and ProtecT Study Group
Journal of Clinical Epidemiology, ISSN 0895-4356, 2019, Volume 113, pp. 200 - 213
AbstractObjectivesRecruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment... 
Internal Medicine | Research participation | Randomization | Randomized trial | Comprehensive cohort | Preferences | Recruitment | SURGERY | DESIGN | LOCALIZED PROSTATE-CANCER | VALIDATION | RADICAL PROSTATECTOMY | CHALLENGES | IMPACT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HEALTH CARE SCIENCES & SERVICES | QUALITY-OF-LIFE | RADIOTHERAPY | EQUIPOISE | Clinical trials | Research | Prostate cancer | Analysis | Oncology, Experimental | Cancer | Signs and symptoms | Risk groups | Medical services | Health risks | Decisions | Risk | Family medical history | Radiation therapy | Cancer therapies | Patients | Design | Biopsy | Prostate | Sociodemographics | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Characterizing the phase purity of nanocrystalline Fe.sub.3O.sub.4 thin films using Verwey transition
by Bohra, Murtaza and Prasad, K. Eswar and Bollina, Ravi and Sahoo, S.C and Kumar, Naresh
Journal of Magnetism and Magnetic Materials, ISSN 0304-8853, 11/2016, Volume 418, p. 137
We have employed Verwey transition as a probe to check phase purity of nanocrystalline Fe.sub.3O.sub.4 films grown at different substrate temperatures... 
Thin films | Magnetization | Anisotropy | Dielectric films | Iron oxides
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
by Donovan, Jenny L and Young, Grace J and Walsh, Eleanor I and Metcalfe, Chris and Lane, J. Athene and Martin, Richard M and Tazewell, Marta K and Davis, Michael and Peters, Tim J and Turner, Emma L and Mills, Nicola and Khazragui, Hanan and Khera, Tarnjit K and Neal, David E and Hamdy, Freddie C and Bollina, Prasad and Catto, James and Doble, Andrew and Doherty, Alan and Gillatt, David and Gnanapragasam, Vincent and Holding, Peter and Hughes, Owen and Kockelbergh, Roger and Kynaston, Howard and Mason, Malcolm and Oxley, Jon and Paul, Alan and Paez, Edgar and Rosario, Derek J and Rowe, Edward and Staffurth, John and ProtecT Study Grp and ProtecT Study Group
Journal of Clinical Epidemiology, ISSN 0895-4356, 04/2018, Volume 96, pp. 35 - 46
Randomized controlled trials (RCTs) deliver robust internally valid evidence but generalizability is often neglected. Design features built into the Prostate... 
Clinical trial | External validity | Randomized | Comprehensive cohort | Generalizability | Prostate cancer | RANDOMIZED CONTROLLED-TRIALS | RECRUITMENT | PRECIS-2 | FOLLOW-UP | RADICAL PROSTATECTOMY | INFORMED-CONSENT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CLINICAL-TRIALS | HEALTH CARE SCIENCES & SERVICES | RADIOTHERAPY | INTERVENTION | Medical research | Antigens | Prostate-specific antigen | Decision making | Feasibility studies | Clinical trials | Population studies | Radiation therapy | Medical screening | Cancer therapies | Patients | Quality of life | Design | Occupation | Mens health | Randomization | Judgments | Surgery | Men | Data collection | Clinical medicine | Prostate | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Response to Editorial Comment “There's a Long Way to Go, But Now We Have a Map”
by Robertson, Jane and McNamee, Phillip and Molloy, Gerry and Hubbard, Gill and McNeill, Alan and Bollina, Prasad and Kelly, Daniel and Forbat, Liz
The Journal of Sexual Medicine, ISSN 1743-6095, 08/2016, Volume 13, Issue 8, pp. 1245 - 1245
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial
by Martin, Richard M and Donovan, Jenny L and Turner, Emma L and Metcalfe, Chris and Young, Grace J and Walsh, Eleanor I and Lane, J. Athene and Noble, Sian and Oliver, Steven E and Evans, Simon and Sterne, Jonathan A.C and Holding, Peter and Ben-Shlomo, Yoav and Brindle, Peter and Williams, Naomi J and Hill, Elizabeth M and Ng, Siaw Yein and Toole, Jessica and Tazewell, Marta K and Hughes, Laura J and Davies, Charlotte F and Thorn, Joanna C and Down, Elizabeth and Smith, George Davey and Neal, David E and Hamdy, Freddie C and Martin, Richard and Donovan, Jenny and Neal, David and Hamdy, Freddie C and Turner, Emma and Athene Lane, J and Noble, Sian and Frankel, Stephen and Bollina, Prasad and Catto, James and Doble, Andrew and Doherty, Alan and Gillatt, David and Gnanapragasam, Vincent and Holding, Peter and Hughes, Owen and Kynaston, Howard and Paul, Alan and Paez, Edgar and Rosario, Derek J and CAP Trial Grp and CAP Trial Group and for the CAP Trial Group
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 03/2018, Volume 319, Issue 9, pp. 883 - 895
IMPORTANCE Prostate cancer screening remains controversial because potential mortality or quality-of-life benefits may be outweighed by harms from... 
INVITATION | MEDICINE, GENERAL & INTERNAL | DESIGN | REDUCTION | GENERAL-PRACTICE | OVERDIAGNOSIS | ERSPC | ROTTERDAM | SECTION | ANTIGEN TESTING RATES | ACCURACY | Age Distribution | Follow-Up Studies | Early Detection of Cancer | Humans | Middle Aged | Male | Prostatic Neoplasms - diagnosis | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Social Class | Mass Screening | Prostatic Neoplasms - blood | Aged | Primary Health Care | United Kingdom - epidemiology | Treatment outcome | Care and treatment | Usage | Prostate-specific antigen | Analysis | Clinical trials | Diagnosis | Prostate cancer | Health care | Intervention | Risk groups | Mortality | Health risks | Medical screening | Screening | Randomization | Biopsy | Quality | Men | Fatalities | Diagnostic systems | Prostate | Cancer | Tumors | Original Investigation | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: Study protocol for a pilot randomised controlled trial
by Robertson, Jane M and Molloy, Gerard J and Bollina, Prasad R and Kelly, Daniel M and McNeill, S A and Forbat, Liz
Trials, ISSN 1745-6215, 05/2014, Volume 15, Issue 1, pp. 183 - 183
Background: Men who undergo surgery for prostate cancer frequently experience significant side-effects including urinary and sexual dysfunction. These... 
Intervention | Psychological | Sexual | Adjustment | Couple | Relationship | Prostate cancer | Counselling | Communication | Functioning | Quality of life | MEDICINE, RESEARCH & EXPERIMENTAL | PSYCHOSOCIAL ADJUSTMENT | 1ST YEAR | COMPLEX INTERVENTIONS | PARTNERS | FAMILY | RADICAL RETROPUBIC PROSTATECTOMY | MEN | PSYCHOLOGICAL DISTRESS | QUALITY-OF-LIFE | SEXUAL DYSFUNCTION | Sexual Dysfunctions, Psychological - therapy | Sexual Dysfunction, Physiological - therapy | Humans | Clinical Protocols | Male | Scotland | Feasibility Studies | Sexual Dysfunctions, Psychological - diagnosis | Couples Therapy - economics | Prostatic Neoplasms - economics | Sexual Dysfunction, Physiological - psychology | Sexual Dysfunctions, Psychological - etiology | Time Factors | Sexual Dysfunctions, Psychological - economics | Urologic Surgical Procedures, Male - adverse effects | Urologic Surgical Procedures, Male - economics | Female | Sexual Behavior | Prostatic Neoplasms - surgery | Treatment Outcome | Sexual Dysfunction, Physiological - economics | Spouses - psychology | Health Care Costs | Pilot Projects | Sexual Dysfunction, Physiological - etiology | Cost-Benefit Analysis | Research Design | Sexual Partners - psychology | Sexual Dysfunction, Physiological - diagnosis | Research | Surgery | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
by Johnston, Thomas J and Shaw, Greg L and Lamb, Alastair D and Parashar, Deepak and Greenberg, David and Xiong, Tengbin and Edwards, Alison L and Gnanapragasam, Vincent and Holding, Peter and Herbert, Phillipa and Davis, Michael and Mizielinsk, Elizabeth and Lane, J. Athene and Oxley, Jon and Robinson, Mary and Mason, Malcolm and Staffurth, John and Bollina, Prasad and Catto, James and Doble, Andrew and Doherty, Alan and Gillatt, David and Kockelbergh, Roger and Kynaston, Howard and Prescott, Steve and Paul, Alan and Powell, Philip and Rosario, Derek and Rowe, Edward and Donovan, Jenny L and Hamdy, Freddie C and Neal, David E and ProtecT Study Grp and ProtecT study group
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 381 - 388
Abstract Background Early detection and treatment of asymptomatic men with advanced and high-risk prostate cancer (PCa) may improve survival rates. Objective... 
Urology | Prostate cancer | Survival | Prostate-specific antigen screening | ANDROGEN-DEPRIVATION THERAPY | TESTING RATES | PHASE-3 TRIAL | UROLOGY & NEPHROLOGY | GENERAL-PRACTICE | FOLLOW-UP | RADICAL PROSTATECTOMY | RADIOTHERAPY | ENGLAND | Prostatic Neoplasms - pathology | Prostatectomy - methods | Early Detection of Cancer | Humans | Middle Aged | Mortality | Male | United Kingdom | Antibodies, Monoclonal | Prostatic Neoplasms - diagnosis | Cause of Death | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Randomized Controlled Trials as Topic | Neoplasm Metastasis | Antineoplastic Agents, Hormonal - therapeutic use | Radiotherapy - methods | Aged | Kallikreins - blood | Eligibility Determination | Cohort Studies | Medical colleges | Hospitals | Oncology, Experimental | Research | Research institutes | Epidemiology | Cancer | Analysis | Platinum Priority – Prostate Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14.